Anzu Partners
Edit

Anzu Partners

https://www.anzupartners.com
Last activity: 29.06.2024
Active
Invests in categories: TechnologyMaterialsBatteryProductManufacturingIndustryPlatformAnalyticsDataHardware
Anzu Partners is a venture capital and private equity firm that invests in breakthrough industrial technologies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations.

Anzu Partners has offices in Washington, DC, San Diego, CA, Boston, MA, and Tampa, FL.
News
335
Portfolio
31
Persons
1
Mentions
34
Location: United States, District of Columbia, Washington
Employees: 11-50
Founded date: 2014
Investment Type: Private Equity Firm; Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; IPO

Portfolio 31

DateNameWebsiteTotal RaisedLocation
02.03.2023TeraPore T...terapore.com$10MUnited Sta...
26.10.2022OTI Lumion...otilumionics.com$85MCanada, On...
30.04.2022CytoTronic...cytotronics.com$9.25MUnited Sta...
15.08.2020InterVenn ...intervenn.bio$244.4MUnited Sta...
15.08.2020Aspinity, ...aspinity.com$10.3MUnited Sta...
11.08.2020ImmunoScap...immunoscape.com$49MSingapore
28.04.2020Ai-Mediaai-media.tv$65.5MAustralia,...
28.04.2020BioFlyte, ...bioflyte.com$12.75MFrance, Bu...
-GelSight, ...gelsight.com$10MUnited Sta...
-Boston Mic...bostonmicrofluidics.com$17.5MPoland, Le...
Show more

Persons 1

DateFirst NameLast NameTitleLinkedIn
---Partner, C...linkedin.c...

News 335

DateTitleDescription
02.11.2023NUBURU Appoints Brian Knaley as new CEOWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
01.11.2023GelSight Unveils New GelSight Mobile Shock Protected EditionWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
31.10.2023Liquid Instruments Enhances Multi-instrument Capabilities, Adds New Instrument Across Test Device PortfolioWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
30.10.2023BioSkryb Genomics to Present New Single-Cell Multiomic Data at ASHG 2023We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
25.10.2023Excision BioTherapeutics Presents Positive Interim Clinical Data from Ongoing Phase 1/2 Trial of EBT-101 for the Treatment of HIV at ESGCT 30th Annual CongressWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
24.10.2023Niron Magnetics’ Clean Earth Magnet Named to TIME’s List of the Best Inventions of 2023We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
19.10.2023AM Batteries Nabs Industry Veterans from Tesla, Celgard to Mass Produce Low CO2 Footprint Li-ion EV BatteriesWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
19.10.2023ImmunoScape Uses Machine Learning to Accurately Predict Antigen Specificity Based on T-Cell Phenotypes in New Peer-Reviewed ResearchWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
19.10.2023Excision BioTherapeutics Announces Presentation of Interim Clinical Data for EBT-101 in Latent HIV at Upcoming European Society of Gene and Cell Therapy (ESGCT) 2023 Annual CongressWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
13.10.2023InterVenn Biosciences Announces the Publication of Early Detection of Advanced Adenoma and Colorectal Cancer in Gastroenterology, the Flagship Journal of the American Gastroenterological AssociationWe use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. Cookie settingsACCEPT
Show more

Mentions in press and media 34

DateTitleDescription
02.07.2024e-Zinc: Powering the Future with Zinc-Air Batteriese-Zinc, a Toronto-based company, is making waves in the energy storage industry with its innovative zinc-air battery technology. Recently securing a whopping $31 million in Series A2 funding, e-Zinc is on a mission to revolutionize the way ...
29.06.2024e-Zinc: Energy Storage Solutions Company Raises $31 Millione-Zinc, a company enabling sustainable, long-duration energy storage with its zinc-air battery, announced it has raised an additional $31 million in follow-on funding to its $25 million Series A round. This oversubscribed Series A2 funding ...
13.06.2024Porsche инвестировала в аккумуляторный стартап South 8, который дает производительность EV в холодную погодуВсе автомобили страдают, когда температура падает, но электромобили страдают больше других, поскольку обогреватели потребляют больше энергии, а батареи заряжаются медленнее, так как жидкий электролит внутри загустевает. South 8 Technologies...
03.06.2024Anzu Partners and J.A. Green seek $100m for defense-tech fund: report-
23.04.2024Framework’s repairability philosophy is set to expand beyond the laptopFramework Computer was ahead of the curve. The company was founded in 2019, as 20 U.S. states began exploring potential right to repair bills. It delivered its first product, the Framework 13, in 2021, a year before New York enacted its lan...
14.03.2024Voxeljet to withdraw from the NASDAQ Stock Exchange and SEC in new cost reduction effortsBinder jet 3D printer manufacturer voxeljet has announced that it will withdraw from the NASDAQ Stock Exchange and terminate its registration with the U.S. Securities and Exchange Commission (SEC). The move, anticipated to be effective from...
27.12.2023AI predictions for 2024: What top VCs thinkJoin leaders in San Francisco on January 10 for an exclusive night of networking, insights, and conversation. Request an invite here. As 2023 draws to a close, it’s a time of reflection on the monumental advances — and ethical debates — sur...
10.10.2023Join VentureBeat and Anzu Partners for our first DC meetup: ‘AI ❤️ DC’VentureBeat is partnering with Anzu Partners on an exclusive gathering for the AI community in Washington DC this coming Thursday, October 26: AI ❤️ DC! Join us for an evening of incisive discussions and high-level networking, spotlighting ...
26.09.2023Anzu Partners Closes Third Venture Fund, At More Than $200MAnzu Partners, an Atlanta, Boston, San Diego, and Tampa-based investment firm delivering capital and strategic support to early-stage breakthrough technology companies, raised more than $200m at the close of its third venture capital fund. ...
10.02.2023Opscura cierra una ronda de €8,7M liderada por Anzu Partners. Participan Dreamit y Mundi Ventures09/02/2023 OPSCURA CIERRA UNA RONDA DE €8,7M LIDERADA POR ANZU PARTNERS. PARTICIPAN DREAMIT Y MUNDI VENTURES Opscura, empresa de ciberseguridad de sistemas de control industrial (ICS), ha cerrado una ronda serie A por importe de $9,4 mill...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In